Abnormalities in the SIRT1-SIRT3 axis promote myocardial ischemia-reperfusion injury through ferroptosis caused by silencing the PINK1/Parkin signalling pathway

Author:

Liao Yunfei1,Ke Ben1,Long Xiaoyan2,Xu Jianjun1,Wu Yongbing1

Affiliation:

1. The Second Affiliated Hospital of Nanchang University

2. East China Digital Medical Engineering Research Institute

Abstract

Abstract Myocardial ischemia-reperfusion injury (MIRI) is the main reason for the poor prognosis of patients with ischemic cardiomyopathy (ICM). To date, the mechanism of MIRI remains unknown. As members of the silent information regulator 2 (SIR2) family, SIRT1 and SIRT3 have been shown to play critical roles in protecting cardiomyocytes against MIRI, but whether SIRT1 and SIRT3 interact to regulate mitophagy and their association with ferroptosis during MIRI have not been reported. Hence, in this study, we investigated the role and specific mechanism of SIRT1 and SIRT3 in protecting cardiomyocytes against MIRI through bioinformatics analysis and cell experiment methods. Meanwhile, we also elucidated the interaction between SIRT1 and SIRT3 during MIRI. We found that the expression of SIRT1 and SIRT3 in myocardial tissues and the peripheral blood of patients with ICM was abnormal, and SIRT1 was significantly negatively correlated with SIRT3 during MIRI. Further analysis revealed that the SIRT1-SIRT3 axis was closely correlated with ferroptosis, and its silencing could effectively increase the incidence of ferroptosis. Furthermore, SIRT1-SIRT3 axis silencing was accompanied by changes in PINK1, Parkin, P62/SQSTM1 and LC3 expression. PINK1 silencing significantly increased the incidence of ferroptosis, while resveratrol (Res) and/or honokiol (HKL) effectively reversed the outcome. These results suggests that abnormalities in the SIRT1-SIRT3 axis promote MIRI through ferroptosis caused by silencing the PINK1/Parkin signalling pathway, which may provide promising therapeutic prospects for patients with ICM.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3